{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:30Z","timestamp":1787028570831,"version":"build-2736575974"},"reference-count":50,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare systemic vasculitis with eosinophilic inflammation and variable clinical presentations. Although skin manifestations are frequent, current classification criteria do not include them, which may underestimate their diagnostic value. This prospective observational study aimed to assess systemic and skin involvement as well as eosinophilia, anti-neutrophil cytoplasmic antibody (ANCA), and Anti-nuclear antibodies (ANA) serum levels in 20 EGPA patients followed for one year at the University Hospital of Messina, Italy, before starting Mepolizumab, 300 mg. Eosinophilia, ANCA status, systemic and skin involvement were also evaluated at 6 and 12 months; a literature review on these data supplements our findings. Skin involvement was present in 55% of patients, including purpura, urticarial vasculitis, angioedema, maculopapular rash, and nodules, mostly in ANCA-negative patients, though purpura was more frequent in ANCA-positive cases but without any statistically significant correlation. ANAs were present in 50% of patients, together with ANCA in two subjects and without in eight. Mepolizumab significantly reduced eosinophil levels, BVASs, and corticosteroid dependence, with notable improvement in skin symptoms. In conclusion, skin manifestations are common in EGPA and may represent useful indicators of disease activity. Their integration with ANCA status, eosinophil counts, and positivity to other autoantibodies could enhance diagnostic and monitoring strategies identifying different clusters of EGPA patients even if the small sample size limits the generalizability of the findings.<\/jats:p>","DOI":"10.3390\/ijms26157472","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:56:16Z","timestamp":1754409376000},"page":"7472","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunological Markers Associated with Skin Manifestations of EGPA"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2855-254X","authenticated-orcid":false,"given":"Silvia","family":"Brunetto","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8582-4008","authenticated-orcid":false,"given":"Federica","family":"Buta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-8347","authenticated-orcid":false,"given":"Luisa","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"ref_1","first-page":"277","article-title":"Allergic granulomatosis; allergic angiitis, periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am. J. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103219","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: A review","volume":"22","author":"White","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1007\/s10067-021-05783-8","article-title":"Burden of illness associated with eosinophilic granulomatosis with polyangiitis: A systematic literature review and meta-analysis","volume":"40","author":"Jakes","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13052-017-0364-x","article-title":"ANCA-associated vasculitis in childhood: Recent advances","volume":"43","author":"Calatroni","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Walulik, A., \u0141ysak, K., B\u0142aszkiewicz, M., G\u00f3recki, I., and Gomu\u0142ka, K. (2023). The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417217"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fagni, F., Bello, F., and Emmi, G. (2021). Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology. Front. Med., 8.","DOI":"10.3389\/fmed.2021.627776"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fijolek, J., and Radzikowska, E. (2023). Eosinophilic granulomatosis with polyangiitis\u2014Advances in pathogenesis, diagnosis, and treatment. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1145257"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaip.2020.07.038","article-title":"Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis","volume":"9","author":"Chang","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liu, S., Han, L., Liu, Y., Yang, J., Zhang, Y., Li, M., Tian, X., Zeng, X., Wang, L., and Zhang, F. (2022). Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.885198"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.55563\/clinexprheumatol\/08k9af","article-title":"Autoantibody profile in eosinophilic granulomatosis and polyangiitis: Predominance of anti-alpha-enolase antibodies","volume":"39","author":"Laskari","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2012.05.058","article-title":"Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome","volume":"131","author":"Healy","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1242273","DOI":"10.3389\/fphar.2023.1242273","article-title":"Editorial: Case reports in respiratory pharmacology 2022","volume":"14","author":"Zdziarski","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides","volume":"96","author":"Fraile","year":"2017","journal-title":"Medicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00296-020-04672-8","article-title":"Presence of purpura is related to active inflammation in association with IL-5 in eosinophilic granulomatosis with polyangiitis","volume":"41","author":"Kataoka","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.22686","article-title":"Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)","volume":"68","author":"Durel","year":"2016","journal-title":"Arthritis Care Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ricciardi, L., Soler, D.G., Bennici, A., Brunetto, S., Pioggia, G., and Gangemi, S. (2022). Case Report: Severe Eosinophilic Asthma Associated With ANCA-Negative EGPA in a Young Adult Successfully Treated With Benralizumab. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.858344"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/art.41310","article-title":"Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody\u2013Associated Vasculitis","volume":"72","author":"Micheletti","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.autrev.2017.09.009","article-title":"Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides","volume":"16","author":"Frumholtz","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/ijd.16214","article-title":"Cutaneous manifestations of ANCA-associated vasculitis: A retrospective review of 211 cases with emphasis on clinicopathologic correlation and ANCA status","volume":"62","author":"Shakshouk","year":"2023","journal-title":"Int. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2500\/aap.2022.43.220056","article-title":"Benralizumab in the management of rare primary eosinophilic lung diseases","volume":"43","author":"Soler","year":"2022","journal-title":"Allergy Asthma Proc."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Watanabe, R., and Hashimoto, M. (2023). Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185996"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Delvino, P., Quartuccio, L., Robson, J.C., Ferretti, V.V., Klersy, C., Alberici, F., Bagnasco, D., Berti, A., Caminati, M., and Camoni, M. (2025). Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study. Rheumatology, keaf232.","DOI":"10.1093\/rheumatology\/keaf232"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"AlBloushi, S., and Al-Ahmad, M. (2024). Exploring the immunopathology of type 2 inflammatory airway diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1285598"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil Cytoplasmic Antibodies and the Churg\u2013Strauss Syndrome","volume":"143","author":"Cohen","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.rdc.2010.05.003","article-title":"Clinical Manifestations and Treatment of Churg-Strauss Syndrome","volume":"36","author":"Baldini","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106933","DOI":"10.1016\/j.imlet.2024.106933","article-title":"The role of neutrophils in ANCA-associated vasculitis","volume":"270","author":"Prendecki","year":"2024","journal-title":"Immunol. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Matucci, A., Vivarelli, E., Perlato, M., Mecheri, V., Accinno, M., Cosmi, L., Parronchi, P., Rossi, O., and Vultaggio, A. (2023). EGPA Phenotyping: Not Only ANCA, but Also Eosinophils. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030776"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hellmark, T., Ohlsson, S., Pettersson, \u00c5., Hansson, M., and Johansson, \u00c5.C.M. (2019). Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis. BMC Rheumatol., 3.","DOI":"10.1186\/s41927-019-0059-6"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-023-03233-1","article-title":"Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis","volume":"25","author":"Ha","year":"2023","journal-title":"Arthritis Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: Characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/abd1806-4841.20175522","article-title":"Cutaneous manifestations of Churg-Strauss syndrome: Key to diagnosis","volume":"92","author":"Marques","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2023.03.017","article-title":"The role of eosinophils in the differential diagnosis of inflammatory skin diseases","volume":"140","author":"Fung","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2665-9913(24)00025-0","article-title":"Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Arnold","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3389\/fmed.2022.824630","article-title":"Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review","volume":"9","author":"Gullo","year":"2022","journal-title":"Front. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11739-021-02688-x","article-title":"Diagnosis and management of leukocytoclastic vasculitis","volume":"16","author":"Fraticelli","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.13170","article-title":"The neutrophil: A key resourceful agent in immune-mediated vasculitis","volume":"314","author":"Aymonnier","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/cup.14065","article-title":"Eosinophilic granulomatosis with polyangiitis: Cutaneous clinical and histopathologic differential diagnosis","volume":"48","author":"Tabb","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.23736\/S2784-8671.24.07713-2","article-title":"Erythema annulare centrifugum as clinical manifestation of-eosinophilic granulomatosis with polyangiitis","volume":"159","author":"Calabrese","year":"2024","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/DAD.0000000000002763","article-title":"A Complex Vasculitis: Thrombophlebitis, Subcutaneous Granulomatous Arteritis, and Eosinophilic Granulomatosis With Polyangiitis Presenting Clinically as Livedo Racemosa With Nodular Erythema","volume":"46","author":"Yamamoto","year":"2024","journal-title":"Am. J. Dermatopathol."},{"key":"ref_44","first-page":"116","article-title":"Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis","volume":"30","author":"Polak","year":"2022","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/pde.14144","article-title":"Cutaneous manifestations of childhood Eosinophilic Granulomatosis with Polyangiitis (cEGPA): A case-based review","volume":"37","author":"Bridges","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/DAD.0000000000001451","article-title":"A Case of Cutaneous Arteritis Presenting as Infiltrated Erythema in Eosinophilic Granulomatosis With Polyangiitis: Features of the Unique Morphological Evolution of Arteritis as a Diagnostic Clue","volume":"41","author":"Shiiyama","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2174\/1871530320999201111160420","article-title":"Distribution Characteristics of ANA and ANCA in Patients with Hyperthyroidism","volume":"21","author":"Xun","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets."},{"key":"ref_48","first-page":"473","article-title":"Frequency of Positive ANCA Test in a Population With Clinical Symptoms Suggestive of Autoimmune Disease and the Interference of ANA in its Interpretation","volume":"16","author":"Villa","year":"2020","journal-title":"Reumatol. Clin."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7472\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:42Z","timestamp":1760034102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":50,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157472"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157472","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]}}}